This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 1997 Apr 16;277(15):1238-43.

Thyroid storm

D Rennie

PMID: 9103350

Editorial

Thyroid storm

D Rennie. JAMA. 1997.

. 1997 Apr 16;277(15):1238-43.

Author

D Rennie

PMID: 9103350

No abstract available

PubMed Disclaimer

Comment in

Bioequivalence of levothyroxine preparations: issues of science, publication, and advertising.
DeGroot LJ. DeGroot LJ. JAMA. 1997 Sep 17;278(11):895; author reply 898-9. doi: 10.1001/jama.278.11.895b. JAMA. 1997. PMID: 9302231 No abstract available.
Bioequivalence of levothyroxine preparations: issues of science, publication, and advertising.
St Germain DL, Ridgway EC. St Germain DL, et al. JAMA. 1997 Sep 17;278(11):895-6; author reply 898-9. doi: 10.1001/jama.1997.03550110033018. JAMA. 1997. PMID: 9302232 No abstract available.
Bioequivalence of levothyroxine preparations: issues of science, publication, and advertising.
Bell BM. Bell BM. JAMA. 1997 Sep 17;278(11):896; author reply 898-9. doi: 10.1001/jama.278.11.896b. JAMA. 1997. PMID: 9302234 No abstract available.
Bioequivalence of levothyroxine preparations: issues of science, publication, and advertising.
Donohoe M. Donohoe M. JAMA. 1997 Sep 17;278(11):896-7; author reply 898-9. doi: 10.1001/jama.1997.03550110034021. JAMA. 1997. PMID: 9302235 No abstract available.
Bioequivalence of levothyroxine preparations: issues of science, publication, and advertising.
Brantigan CO. Brantigan CO. JAMA. 1997 Sep 17;278(11):897; author reply 898-9. doi: 10.1001/jama.278.11.897d. JAMA. 1997. PMID: 9302236 No abstract available.
Bioequivalence of levothyroxine preparations: issues of science, publication, and advertising.
Lankin KM. Lankin KM. JAMA. 1997 Sep 17;278(11):897; author reply 898-900. doi: 10.1001/jama.278.11.897b. JAMA. 1997. PMID: 9302238 No abstract available.
Bioequivalence of levothyroxine preparations: issues of science, publication, and advertising.
Birnbaum R. Birnbaum R. JAMA. 1997 Sep 17;278(11):897-8; author reply 898-900. doi: 10.1001/jama.1997.03550110035025. JAMA. 1997. PMID: 9302239 No abstract available.

Comment on

Perspectives for the treatment of osteoporosis.
Rico H. Rico H. Calcif Tissue Int. 1997 Feb;60(2):135-8. doi: 10.1007/s002239900203. Calcif Tissue Int. 1997. PMID: 9056160 No abstract available.
Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism.
Dong BJ, Hauck WW, Gambertoglio JG, Gee L, White JR, Bubp JL, Greenspan FS. Dong BJ, et al. JAMA. 1997 Apr 16;277(15):1205-13. JAMA. 1997. PMID: 9103344 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information